3m CO 10-Q quarterly reports

3M Company announced its Q2 2026 financial results, showing increased net sales and operating income, while continuing to address significant legal and environmental liabilities.

3M Company's Q1 2026 filing reveals a dip in net income and EPS compared to the prior year, alongside significant ongoing legal and environmental provisions, particularly related to PFAS litigation.

3M reports a 3.5% increase in net sales for Q3 2025, driven by strength in safety and electronics, but GAAP EPS declined significantly due to special items including litigation charges.

3M's second quarter 2025 GAAP earnings per share declined significantly due to substantial legal settlement charges, while adjusted results showed growth, as the company continues its PFAS manufacturing exit and manages ongoing litigation.

3M's Q1 2025 earnings per share jumped 61% to $2.04, driven by productivity and lower restructuring costs, even as sales dipped slightly to $5.95 billion.

3M's Q3 2024 results show a mixed performance with a net income of $1.37 billion, influenced by the spin-off of Solventum and ongoing litigation settlements.

3M's Q2 2024 results reflect the impact of the Solventum spin-off, ongoing restructuring efforts, and significant charges related to PFAS litigation, while also showing some underlying operational improvements.

3M Company's first quarter 2024 results show a slight decrease in sales but an increase in operating income, alongside significant restructuring and the spin-off of its healthcare business.